Tag Archives: Disease

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

Home News New Drugs FDA Approves Yupelri FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page November 09, 2018 — Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Revefenacin is a long-acting muscarinic antagonist… Read More »

Priority Review Vouchers Revitalizing Neglected Disease Drug Development

FILE – On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a one-dose treatment to prevent relapses of malaria. (AP Photo/Kirsty Wigglesworth, File) Neglected tropical diseases (NTDs) impact more than one in six people worldwide, often the poorest, but are allocated less than 0.5 percent of global pharmaceutical investment. Yet, new… Read More »